New patent for Amicus Therap drug GALAFOLD – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent for Amicus Therap drug GALAFOLD
Annual Drug Patent Expirations for GALAFOLD
Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are thirty-five patents protecting this drug.
This drug has one hundred and twenty-two patent family members in twenty-eight countries.
The generic ingredient in GALAFOLD is migalastat hydrochloride. Additional details are available on the migalastat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
Copyright © DrugPatentWatch. Originally published at New patent for Amicus Therap drug GALAFOLD
Related
EHS